CNTA Stock Analysis: Buy, Sell, or Hold?
CNTA - Centessa Pharmaceuticals plc American Depositary Shares
$24.57
-0.32 (-1.29%)
▼
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 23, 2026
Get Alerted When CNTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CNTA shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: CNTA shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CNTA is currently trading at $24.57, which is considered extended relative to its 30-day fair value range of $22.46 to $25.15.
Technical Outlook: Technically, CNTA is in a uptrend. Immediate support is located at $21.50, while resistance sits at $26.63.
Market Sentiment: CNTA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $39.62 (+61.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CNTA is in a uptrend. Immediate support is located at $21.50, while resistance sits at $26.63.
Market Sentiment: CNTA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $39.62 (+61.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$22.46 -
$25.15
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 61.2% below Wall St target ($39.62)
Fair Price Analysis
30-Day Fair Range
$22.46 -
$25.15
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$21.50
Resistance Level
$26.63
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-14.66
Wall Street Target
$39.62
(+61.2%)
Last updated: February 01, 2026 12:32 PM ET
Data refreshes hourly during market hours. Next update: 1:32 PM
Data refreshes hourly during market hours. Next update: 1:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNTA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Iqbal J Hussain
SELL
6000 shares
2025-10-15
Tia L Bush
SELL
35000 shares
2025-09-24
Mario Alberto Accardi
SELL
8172 shares
2025-09-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 52 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$93 | 59 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 62 BUY |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 56 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$34 | 51 HOLD |
Advanced CNTA Option Strategies
Professional options setups generated by AI based on today's CNTA price and gamma walls.
